Dr Lalchandani Labs Approves Audited FY26 Financial Results

Dr Lalchandani Labs Ltd announced the approval of its audited standalone financial results for the fiscal year ended March 31, 2026. The Board of Directors, in a meeting held on June 3, 2026, also appointed M/s. Brickwork Ratings India Private Limited as the new Monitoring Agency for the utilization of Rights Issue Proceeds, replacing M/s. Infomerics Valuation and Ratings Limited. The company reported a waiver of Rs. 61.08 lacs under an One Time Settlement (OTS) scheme for its unsecured loans. The financial statements indicate total assets of Rs. 1,760.05 Lacs and total equity and liabilities of Rs. 1,760.08 Lacs as of March 31, 2026. The company also provided cash flow statements, showing net cash flow from operating activities at (₹76.46) Lacs and from investing activities at (₹50.94) Lacs, while financing activities generated ₹211.74 Lacs.